Clare Barlow

695 total citations
7 papers, 76 citations indexed

About

Clare Barlow is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Clare Barlow has authored 7 papers receiving a total of 76 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Pulmonary and Respiratory Medicine and 2 papers in Immunology. Recurrent topics in Clare Barlow's work include Advanced Breast Cancer Therapies (2 papers), CAR-T cell therapy research (2 papers) and Immunotherapy and Immune Responses (2 papers). Clare Barlow is often cited by papers focused on Advanced Breast Cancer Therapies (2 papers), CAR-T cell therapy research (2 papers) and Immunotherapy and Immune Responses (2 papers). Clare Barlow collaborates with scholars based in United Kingdom, Netherlands and Belgium. Clare Barlow's co-authors include Stuart C. Wilson, Paul Workman, Steven R. Whittaker, Edward McDonald, Wayne Jackson, Peter M. Fischer, Nathan J. Brown, Annette J. Self, Swee Y. Sharp and M.E.M. Noble and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Bioorganic & Medicinal Chemistry.

In The Last Decade

Clare Barlow

6 papers receiving 76 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Clare Barlow United Kingdom	4	40	35	33	12	11	7	76
Sara Costa-Cabral United Kingdom	5	72 1.8×	39 1.1×	144 4.4×	16 1.3×	18 1.6×	6	193
Kanthinh Manivong United States	3	32 0.8×	11 0.3×	57 1.7×	3 0.3×	16 1.5×	5	89
Hayley Donnella United States	5	33 0.8×	26 0.7×	65 2.0×	4 0.3×	5 0.5×	6	112
Björn Stolte United States	2	95 2.4×	51 1.5×	121 3.7×	3 0.3×	17 1.5×	3	162
Sara Marlow United States	2	33 0.8×	25 0.7×	124 3.8×	4 0.3×	19 1.7×	2	135
Adelyn Wise United Kingdom	4	71 1.8×	18 0.5×	90 2.7×	14 1.2×	8 0.7×	5	112
Andrey Rymar United States	3	36 0.9×	25 0.7×	78 2.4×	15 1.3×	30 2.7×	4	92
Tam Tran Switzerland	4	48 1.2×	14 0.4×	83 2.5×	2 0.2×	9 0.8×	5	101
Eileen Ambing United States	2	65 1.6×	77 2.2×	95 2.9×	10 0.8×	10 0.9×	2	150
Dongdong Zhan China	8	23 0.6×	23 0.7×	85 2.6×	3 0.3×	5 0.5×	16	146

Countries citing papers authored by Clare Barlow

Since Specialization

Citations

This map shows the geographic impact of Clare Barlow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clare Barlow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clare Barlow more than expected).

Fields of papers citing papers by Clare Barlow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clare Barlow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clare Barlow. The network helps show where Clare Barlow may publish in the future.

Co-authorship network of co-authors of Clare Barlow

This figure shows the co-authorship network connecting the top 25 collaborators of Clare Barlow. A scholar is included among the top collaborators of Clare Barlow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clare Barlow. Clare Barlow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Shaw, Heather, Poulam M. Patel, Miranda Payne, et al.. (2025). Abstract LB214: A DNA plasmid melanoma cancer vaccine, SCIB1, combined with nivolumab + ipilimumab in patients with advanced unresectable melanoma: Efficacy and safety results from the open-label Phase 2 SCOPE Trial. Cancer Research. 85(8_Supplement_2). LB214–LB214.

2.

Shaw, Heather M., Miranda Payne, Satish Kumar, et al.. (2024). A DNA plasmid melanoma cancer vaccine, SCIB1, combined with nivolumab + ipilimumab in patients with advanced unresectable melanoma: Efficacy and safety results from the open-label phase 2 SCOPE trial.. Journal of Clinical Oncology. 42(16_suppl). 9535–9535. 1 indexed citations

3.

Whittaker, Steven R., Clare Barlow, Mathew P. Martin, et al.. (2017). Molecular profiling and combinatorial activity of CCT068127: a potent CDK2 and CDK9 inhibitor. Molecular Oncology. 12(3). 287–304. 31 indexed citations

4.

Glasspool, Rosalind, Iain A. McNeish, James Paul, et al.. (2016). NiCCC (ENGOT-GYN1): A randomized phase II study of nintedanib (BIBF1120) compared to chemotherapy in patients with recurrent clear-cell carcinoma of the ovary or endometrium.. Journal of Clinical Oncology. 34(15_suppl). TPS5603–TPS5603. 3 indexed citations

5.

Wilson, Stuart C., Butrus Atrash, Clare Barlow, et al.. (2011). Design, synthesis and biological evaluation of 6-pyridylmethylaminopurines as CDK inhibitors. Bioorganic & Medicinal Chemistry. 19(22). 6949–6965. 26 indexed citations

6.

Vidal, Laura, Clare Barlow, Beatriz Pardo, et al.. (2010). Phase I clinical and pharmacokinetic study of trabectedin and carboplatin in patients with advanced solid tumors. Investigational New Drugs. 30(2). 616–628. 14 indexed citations

7.

Barlow, Clare & Robin Rudd. (2003). Chemotherapy and radiotherapy of bronchial carcinoma. Hospital Medicine. 64(3). 144–149. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact